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HB-GAM (heparin-binding growth-associated molecule) is a secretory, extracellular matrix-associated protein that was
isolated by screening for proteins that enhance neurite outgrowth in perinatal rat brain neurons. In the present study we
have investigated the possible role of HB-GAM in cell proliferation in the developing rat limb. Exogenously added recombi-
nant HB-GAM was found to inhibit the proliferation of mesenchymal and epithelial cells in cultured limb buds, as
demonstrated by bromodeoxyuridine incorporation and by staining for PCNA (proliferating cell nuclear antigen). The
inhibitory effect of HB-GAM on cell proliferation was reversed by heparin, suggesting that HB-GAM may bind to a heparin-
type carbohydrate epitope that is required for cell proliferation in the developing limb. Endogenous HB-GAM of the
developing limb was found to be expressed in a proximal-to-distal pattern, in agreement with the putative role in prolifera-
tion arrest and cell differentiation. In addition, double immunostaining of HB-GAM with PCNA showed that in early
(Embryonic Day 12) limb mesenchyme HB-GAM was associated mainly with the surface of growth-arrested cells. Further-
more, HB-GAM was associated with the muscle surface, as demonstrated in double immunostaining of HB-GAM with
desmin and myosin heavy chain proteins. Coinciding with the onset of synapse formation (Embryonic Day 16), HB-GAM
was found in patches on the muscle cell surface in close proximity to nicotinic acetylcholine receptor clusters. This ®nding
is in agreement with a previous study that has suggested a role for HB-GAM in the differentiation of the neuromuscular
junction in Xenopus muscle. q 1996 Academic Press, Inc.
INTRODUCTION The HB-GAM protein consists of a 136-amino-acid se-
quence that contains abundantly (24%) cationic, mainly ly-HB-GAM (heparin-binding growth-associated molecule)
sine, residues and ®ve intra-chain disul®de bonds. Thewas isolated from rat brain as an 18-kDa neurite outgrowth-
cDNA predicts a classic-type secretion signal that has beenpromoting protein (p18), and its expression in brain tissue
shown to be cleaved upon rapid secretion of the proteinpeaks during the perinatal stage of rapid axon growth and
from cells (Raulo et al., 1992). The HB-GAM sequence issynapse formation (Rauvala, 1989). The same protein was
highly conserved across species with more than 90% iden-isolated from uterus as a mitogen for ®broblastic cells (Mil-
tity among chicken, rat, bovine, and human (Hampton etner et al., 1989). Molecular cloning and sequencing of p18
al., 1992; Li et al., 1990; Merenmies and Rauvala, 1990).con®rmed that it has a novel sequence, and the protein was
The HB-GAM sequence is clearly distinct from ®broblastnamed HB-GAM due to its association with axon growth
growth factors but is about 50% homologous to the se-(Merenmies and Rauvala, 1990). Cloning of the correspond-
quences of the mouse midkine protein (MK) (Kadomatsu eting mitogenic protein, designated pleiotrophin (Li et al.,
al., 1988; Matsubara et al., 1990; Nakamoto et al., 1992) and1990), revealed the same sequence, con®rming that the pro-
the MK-type chicken protein RIHB (retinoic acid-inducedteins de®ned as HB-GAM and pleiotrophin are identical. In
heparin-binding protein) (Vigny et al., 1989; Urios et al.,addition, the same protein has been found in a number of
1991). HB-GAM, MK, and RIHB thus de®ne a novel familystudies aimed at the identi®cation of proteins that play roles
of heparin-binding proteins that appear to play various rolesin cell and tissue development (Kuo et al., 1990; Tezuka et
al., 1990; Kretschmer et al., 1991; Hampton et al., 1992). in development.
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Rauvala, 1990) was used to prepare the probes. Digoxigenin-labeledThe HB-GAM and MK proteins have been shown to en-
single-stranded sense and antisense RNA probes were generatedhance neurite outgrowth in a number of studies (Rauvala,
with a digoxigenin RNA labeling kit according to the manufactur-1989; Li et al., 1990; Kuo et al., 1990; Kretschmer et al.,
er's speci®cations (Boehringer Mannheim, Germany). Brie¯y, the1991; Hampton et al., 1992; Muramatsu and Muramatsu,
construct in Bluescript was linearized with BamHI and XhoI (Pro-1991; Nurcombe et al., 1992; Michikawa et al., 1993). Cor-
mega) for preparation of the sense and antisense probes, respec-
respondingly, HB-GAM has been recently demonstrated in tively. After linearizing the template DNA, T7 and T3 RNA poly-
extracellular tracts that line the paths of growing neurites merases were used to generate sense and antisense probes, respec-
in the developing brain (Rauvala et al., 1994; Matsumoto tively. The digoxigenin-labeled probes were ethanol-precipitated,
et al., 1994). A mitogenic activity also has been suggested resuspended in diethyl pyrocarbonate-treated water, and stored at
for HB-GAM (Milner et al., 1989; Li et al., 1990). The prolif- 0807C until used. For in situ hybridization, the limbs from embry-
onic days E11, E12, E13, E15, E17, and Postnatal Day 0 (P0) wereeration-enhancing activity is a controversial issue since no
dissected and ®xed immediately in 4% PFA. Cryostat sections wereactivity has been found in other studies (Kuo et al., 1990;
mounted on aminoalcylsilane-coated glasses and stored at 0207CKretschmer et al., 1991; Raulo et al., 1992; Hampton et
until used. In situ hybridization was carried out according to Noloal., 1992). It seems clear that the protein secreted in the
et al. (1996). The sections were embedded in Aquamount (BDHbaculovirus-expression system is not mitogenic and that
Laboratory Supplies, England) and examined with a Leitz Dialuxthe mitogenic activity can also be separated from HB-GAM
microscope.
in the isolation of the protein from the brain under nondena- RecombinantHB-GAMandAnti-HB-GAM antibodies. Recom-
turing conditions (Raulo et al., 1992). It thus appears that binant HB-GAM was produced with the aid of a baculovirus vector
HB-GAM itself is not mitogenic although it copuri®es with and puri®ed to apparent homogeneity as described previously
mitogenic proteins in heparin±Sepharose af®nity chroma- (Raulo et al., 1992).
tography. Two different af®nity-puri®ed antibodies were used to study HB-
The present study was aimed at clarifying whether HB- GAM expression in all limb regions discussed in the paper. The
antibodies referred to as ``anti-peptide'' were produced to a syn-GAM is involved in cell proliferation or in cell differentia-
thetic N-terminal peptide of HB-GAM, and they were af®nity-puri-tion. Developing limb was used for these studies since it
®ed as described previously (Rauvala, 1989). These antibodies wereprovides an excellent system for de®ning signals required
shown to bind to puri®ed HB-GAM in ELISA assays and in Westernfor proliferation and differentiation.
blotting, and they were also found to detect HB-GAM speci®callyWe report here that exogenously added HB-GAM inhibits
in Western blotting of crude tissue extracts (Rauvala, 1989). Thethe proliferation of mesenchymal and, to a lesser degree,
anti-peptide antibodies have been previously shown to bind spe-
epithelial cells in the developing rat limb. The involvement ci®cally to HB-GAM in immunohistochemistry (Rauvala et al.,
of cell matrix structures is suggested by the ®nding that 1994; Mitsiadis et al., 1995). Production of rabbit antisera to the
heparin reverses the proliferation arrest induced by HB- puri®ed recombinant HB-GAM was previously described (Raulo et
GAM. We also provide evidence that suggests a role for al., 1992). Antibodies referred to as ``anti-recombinant HB-GAM''
endogenous HB-GAM in inducing proliferation arrest in were af®nity-puri®ed from these sera as described previously (Peng
et al., 1995). These antibodies have been characterized using West-limb mesenchyme; i.e., the localization of the HB-GAM
ern blotting (Raulo et al., 1992; Peng et al., 1995) and immunohisto-mRNA and protein during limb development indicates that
chemistry (Peng et al., 1995).HB-GAM is mainly expressed in differentiating cells that
Immuno¯uorescence microscopy. Four percent PFA ®xedhave ceased cell division. A role in muscle development is
limbs were cryosectioned at 7±10mm and mounted on 2% aminoal-suggested by the coexpression of HB-GAM during develop-
cylsilane-coated glasses. Unless otherwise stated, all incubationsment with two muscle-speci®c gene products, desmin and
were carried out in PBS containing 5% bovine serum albuminemyosin heavy chain protein, and by its colocalization with
(BSA) and 0.1% Triton X-100. The sections were exposed to the
nicotinic acetylcholine receptor clusters. polyclonal anti-HB-GAM antibodies, either anti-peptide or anti-
recombinant, followed by af®nity-puri®ed ¯uorescein isothiocya-
nate (FITC)-conjugated goat anti-rabbit IgG (Jackson Immunore-
MATERIALS AND METHODS search Laboratories Inc., West Grove, PA). The specimens were
then mounted in Aquamount (BDH Laboratory Supplies, England)
and examined with an Olympus ¯uorescence microscope equippedEmbryos and organs. Sprague±Dawley rats were paired over-
with appropriate ®lters. Samples in which the primary antibodiesnight, and the ®rst 24 hr after placing the rats together were de®ned
were omitted or which contained non-immune rabbit IgG wereas Embryonic Day 0 (E0). Pregnant females were killed by cervical
analyzed in parallel in all experiments.dislocation, and the uterus was removed and put into ice-cold Dul-
The expression of HB-GAM in myogenic cells was studied bybecco's phosphate-buffered saline (PBS; pH 7.4). Hindlimbs and
double immunostaining using rabbit polyclonal antibodies to HB-forelimbs were dissected under a stereomicroscope. The specimens
GAM (see above) and mouse monoclonal antibodies to desminwere immediately immersed in 4% paraformaldehyde (PFA) in PBS
(Boehringer Mannheim) as well as mouse monoclonal antibodies(pH 7.4) overnight at 47C. After cryoprotection in 30% sucrose, the
to skeletal myosin heavy chain protein (MF20; Developmentalspecimens were frozen on dry ice and stored at 0807C. For some
Studies Hybridoma Bank, USA). The bound antibodies were de-experiments un®xed limbs were frozen on dry ice and stored at
tected with af®nity-puri®ed FITC-conjugated goat anti-rabbit IgG0807C until sectioned.
and with af®nity-puri®ed tetramethylrhodamine (TRITC)-conju-Probes and in situ hybridization. The 1.25-kb cDNA con-
taining the whole coding sequence of HB-GAM (Merenmies and gated goat anti-mouse IgG (Jackson Immunoresearch Laboratories
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Inc.), respectively. Expression of HB-GAM in neurite tracts was mg/ml) followed by af®nity-puri®ed TRITC-conjugated goat anti-
mouse IgG. Every individual section was viewed for the PCNA-demonstrated in a similar manner by double immunostaining with
mouse monoclonal antibodies to GAP-43/neuromodulin (Boeh- positive cells with the conventional ¯uorescence microscope
equipped with the appropriate ®lers. The effect of exogenous factorsringer Mannheim) and by double immunostaining with mouse
on limb development was also studied by PCNA staining of themonoclonal anti-neuro®lament antibodies. The anti-neuro®lament
limbs as whole mounts. The limbs were ®xed with 4% PFA afterantibody (obtained from Dr. I. Virtanen, University of Helsinki)
the 44-hr culture (see above). To remove the unspeci®c staining duedetects the 70 and 200 kDa polypeptides of the neuro®lament pro-
to endogenous peroxidase, the explants were incubated in absolutetein as described previously (Virtanen et al., 1985).
methanol containing 1.2% H2O2 (RT, 15 min). To quench the ex-To study the possible relationship between HB-GAM and devel-
cess aldehydes, the limbs were incubated in 0.5% sodium borohy-oping neuromuscular synapses, the samples were incubated with
dride in PBS (RT, 20 min). After extensive washings in PBS±Tritonanti-HB-GAM antibodies followed by af®nity-puri®ed FITC-conju-
X-100, the limbs were exposed to the monoclonal anti-PCNA anti-gated goat anti-rabbit IgG and TRITC-labeled a-bungarotoxin (Mo-
bodies (5 mg/ml) in 5% BSA±Triton X-100±PBS overnight at 47C.lecular Probes, Inc., Eugene) for endplate detection of the samples.
After washing with 0.4% PBS±Triton X-100 the limbs were reactedThe relationship between endogenous HB-GAM expression and
with peroxidase-coupled rabbit anti-mouse IgG (Dakopatts a/s,cell proliferation was studied by double immunostaining using
Denmark) for 1 hr at room temperature. The reaction was devel-polyclonal anti-HB-GAM antibodies and monoclonal antibodies to
oped with diaminobenzidine (0.5 mg/ml in PBS, pH 7.4) containingthe proliferating cell nuclear antigen (PCNA; clone PC10; Boeh-
0.03% H2O2. The specimens were viewed with the Nikon Diaphot-ringer Mannheim). Samples double-labeled for HB-GAM and for
TMD inverted microscope and the PCNA-labeled cells werePCNA were examined using conventional ¯uorescence microscopy
counted.as stated above and laser-scanning microscopy (LSM 410 invert
Laser Scan microscope, Zeiss, Germany).
Organ culture. E12 rat embryos were placed in cold Dulbecco's
phosphate-buffered saline containing 100 U penicillin G/ml and RESULTS
0.1 mg streptomycin/ml. Limb regions were isolated by traverse
cuts through the trunk, and the trunks with attached limbs were Exogenous HB-GAM Inhibits Cell Proliferation intransferred to 1.5-ml tubes (Nunc, Denmark) containing 1.5 ml of
Mesenchymal and Epithelial Cells of Limb Budsmodi®ed serum-free Bigger's medium (ICN Biomedicals Inc., UK)
supplemented with 100 U penicillin G/ml, 0.1 mg streptomycin/ Serum-free cultures of limb buds were used to study the
ml, and 10 mg/ml of BSA. effect of exogenously added factors on cell proliferation.
The limbs were grown at 377C in an atmosphere of 5% CO2 in Evaluation of DNA synthesis from BrdU incorporation re-
the presence of recombinant basic ®broblast growth factor (bFGF,
vealed a striking inhibition of cell proliferation at an HB-10±100 ng/ml; Promega, Madison) or recombinant HB-GAM (100±
GAM concentration of 100 ng/ml. The inhibition appeared1000 ng/ml) or in the presence of both factors. In some experiments
virtually complete in the mesenchyme and was also clearlythe limbs were grown in the presence of HB-GAM (100 ng/ml)
observed in the epithelium (Fig. 1). For quantitative evalua-together with heparin (100±1000 ng/ml, low molecular weight,
tion, hindlimbs from three independent experiments (a totalSigma) or in the presence of heparin (100±1000 ng/ml) alone. In
of eight limbs) were sectioned at 10 mm, and all BrdU-la-addition, some limbs were grown in the presence of recombinant
amphoterin (100±1000 ng/ml). Limbs grown in the medium with- beled cells from the epithelium and the mesenchyme of
out any added growth factors were included as controls in all experi- every individual section were counted. This analysis con-
ments. After 24 hr of culture the factors described above were added ®rmed the nearly complete inhibition of cell proliferation
to the medium for another 20 hr, after which the limbs were ®xed in the mesenchyme and the pronounced inhibition of epi-
in 4% PFA in PBS and analyzed for proliferating cells. thelial cell proliferation (Fig. 2).
Bromodeoxyuridine (BrdU) labeling of the cultured limbs. The Strong binding to heparin and the lysine-rich sequence
limbs grown in culture (a total of 28 limbs), with exogenous factors
(24% cationic residues) are characteristic features of HB-described above, were labeled with BrdU for the last 14 hr of a
GAM (Merenmies and Rauvala, 1990). To study whether44-hr culture period according to the manufacturer's instructions
another lysine-rich protein that binds strongly to heparin(Amersham Life Sciences). After a brief washing in Dulbecco's
might also inhibit cell proliferation under the conditionsphosphate-buffered saline the limbs were ®xed with 4% PFA, cryo-
used, we tested the effect of amphoterin (28% cationic resi-protected in 30% sucrose, and cryosectioned consecutively along
their proximal±distal axis at 10 mm. The consecutive sections were dues; Merenmies et al., 1991) in parallel with HB-GAM.
reacted with the monoclonal anti-BrdU antibodies (Amersham Life Amphoterin produced with the same baculovirus expres-
Sciences) overnight at 47C. The bound antibodies were revealed sion system and puri®ed in a manner similar to that of HB-
with af®nity-puri®ed TRITC-conjugated goat anti-mouse IgG. The GAM (Parkkinen et al., 1993) failed to give any inhibition
sections were then examined by ¯uorescence microscopy, and the in cell proliferation at a concentration of 100 ng/ml (Figs.
BrdU-positive cells from the epithelium and the mesenchyme of 1 and 2). In fact, no inhibitory effect was observed at an
each individual section were counted.
amphoterin concentration as high as 1 mg/ml (not shown).PCNA expression in cultured limbs. Limbs (a total of 20) that
Recent studies have shown that ®broblast growth factorshad been cultured in the presence or absence of exogenous factors
are potent enhancers of cell proliferation in the developingwere ®xed in 4% PFA in PBS and then cryoprotected in 30% sucrose
limb (Niswander and Martin, 1993; Niswander et al., 1993,at 47C overnight. In some experiments the limbs were sectioned
1994; Fallon et al., 1994). Therefore, in some experimentsconsecutively along their proximal±distal axis on cryostat at 10 mm
and immunostained with the monoclonal anti-PCNA antibodies (5 bFGF was added to the culture medium either alone or in
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FIG. 1. HB-GAM-induced proliferation arrest in limb buds. Hindlimbs prepared from E12 embryos were grown in a modi®ed Bigger's
medium for 44 hr in the absence of any added growth factor (A), in the presence of 100 ng/ml of HB-GAM (B), in the presence of 100 ng/
ml of HB-GAM plus 100 ng/ml of heparin (C), or in the presence of 100 ng/ml of amphoterin (D). The limb buds were allowed to incorporate
BrdU for the last 14 hr of their culture, after which they were ®xed with 4% PFA and cryosectioned consecutively at 10 mm. Sections
were stained with the monoclonal anti-BrdU antibodies followed by TRITC-conjugated goat anti-mouse IgG. Every individual section was
viewed for the presence of BrdU-positive cells (a total of 243 sections). Bar for A±D, 35 mm.
combination with HB-GAM. bFGF alone displayed a clear heparin (Figs. 1 and 2). Interestingly, heparin (100 ng/ml)
added alone appears to enhance mesenchymal cell prolifera-proliferation-enhancing effect under the conditions used
(Fig. 2). Interestingly, a 10-fold molar excess of HB-GAM tion in the limb bud (Fig. 2).
suppressed the mitogenic effect of bFGF (Fig. 2). The effect
was more pronounced in the mesenchyme compared to that
observed in the epithelium (Fig. 2). HB-GAM Reduces Expression of the PCNA Cyclin
in the Limb Mesenchyme
Changes in the expression of PCNA (proliferating cellThe Inhibitory Effect of HB-GAM on Cell
nuclear antigen) cyclin, a protein required by DNA polymer-Proliferation Is Reversed by Heparin
ase d during DNA replication, offer one explanation for dif-
ferences in DNA synthesis in developing cells (Bravo et al.,Since HB-GAM binds strongly to heparin (Rauvala, 1989)
and associates with heparan sulfates in cells and tissues 1987; Prelich et al., 1987; Jaskulski et al., 1988). We there-
fore tested whether HB-GAM and bFGF induce changes in(Raulo et al., 1994; Peng et al., 1995), we tested, in two
separate experiments, whether exogenously added heparin PCNA expression in the limb buds. A total of 20 limbs
were examined for PCNA-positive cells. Under the culturehas any effect on the proliferation-inhibiting effect of HB-
GAM. No inhibition on cell proliferation could be observed conditions used, the proliferation-enhancing effect of bFGF
could be observed at 10 ng/ml, based on the increase inin any of the six limbs examined when 100 ng/ml HB-GAM
was added in the presence of either 100 ng/ml or 1 mg/ml PCNA-positive cells (Fig. 3). As with BrdU, HB-GAM at 100
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ng/ml (not shown). Thus, high FGF concentrations neutral-
ize the inhibitory effect of HB-GAM, as does heparin (see
above).
Endogenous HB-GAM Expression in Early (E12)
Mesenchyme and Its Relationship to Cell
Proliferation
In situ hybridization and immunohistochemistry were
used to evaluate endogenous HB-GAM expression in the
developing limb. In situ hybridization showed that HB-
GAM is expressed in the mesenchyme in a proximal-to-
distal pattern (Fig. 4), suggesting its association with cell
differentiation rather than cell proliferation. In the distal
mesenchyme only low expression of HB-GAM mRNA was
detected in cell layers just below the epithelium (Fig. 4).
The HB-GAM mRNA was not detected in the epithelium.
The HB-GAM protein was strongly detected by immuno-
histochemistry in the basement membrane below the epi-
thelium from E11 until birth (not shown). As expected from
in situ hybridization (Fig. 4), the HB-GAM protein was also
clearly detected in the proximal but not in the distal mesen-
FIG. 2. Quantitative evaluation of the proliferation-inhibiting ef-
fect of HB-GAM. The assay was carried out as in Fig. 1. (1) Control
without an exogenous factor; (2) 100 ng/ml of HB-GAM; (3) 100
ng/ml of HB-GAM plus 100 ng/ml of heparin; (4) 100 ng/ml of
heparin; (5) 10 ng/ml of bFGF; (6) 10 ng/ml of bFGF plus 100 ng/
ml of HB-GAM; (7) 100 ng/ml of amphoterin. For quantitative eval-
uation a total of 28 limbs were consecutively sectioned at 10 mm
(a total of 335 sections), and all BrdU-positive cells from each indi-
vidual section were counted. The mean value per section of BrdU-
positive cells in the epithelium of the control limbs (column 1)
was designated 100, and all other numbers of BrdU-positive cells
are given relative to this value. Columns 1 and 2 refer to mean
values from three independent experiments (14 hindlimbs; 135 sec-
tions). Columns 3 and 4 refer to two independent experiments (10
hindlimbs; 116 sections). Standard errors of the means are repre-
sented by vertical bars. Columns 5±7 refer to one experiment (a
total of 84 sections) (see also Fig. 3 for the effect of bFGF alone and
for the effect of bFGF in combination with HB-GAM).
FIG. 3. HB-GAM reduces PCNA expression in the limb. The fore-
limbs were cultured as in Fig. 1 without any added factor (columnng/ml (Fig. 3) and at higher concentrations (not shown),
1), in the presence of 10 ng/ml of bFGF (column 2), in the presencereduced the extent of cell proliferation evaluated from the
of 100 ng/ml of HB-GAM (column 3), or in the presence of 10 ng/number of PCNA-positive cells. Only slight or no effect
ml of bFGF plus 100 ng/ml of HB-GAM (column 4). A total of 16was observed in the epithelium by PCNA staining but the
limbs were examined for PCNA-positive cells. The limb buds wereinhibitory effect of HB-GAM was essentially restricted to
®xed with 4% PFA and stained as whole mounts with monoclonal
the mesenchyme (not shown). anti-PCNA antibodies. The PCNA-positive cells were counted
As with BrdU, 100 ng/ml of HB-GAM was suf®cient to from ®ve random microscopic ®elds of each limb bud, and the
suppress the proliferation-enhancing effect of 10 ng/ml of average number of proliferating cells/®eld was counted and is indi-
bFGF (Fig. 3). No inhibitory effect by HB-GAM could be cated in the ®gure. The error bars give the SEM values from three
separate experiments.observed when the bFGF concentration was raised to 100
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FIG. 4. HB-GAM mRNA in developing rat limb. Sections from E12 forelimb (A) and E13 hindlimb (B) were hybridized with a digoxigenin-
labeled HB-GAM anti-sense probe that was detected with monoclonal anti-digoxigenin antibodies. HB-GAM mRNA is detected in the
proximal mesenchyme and accumulates to differentiating muscle masses (B). A weak signal is detected in the distal mesenchyme (B).
Signi®cant binding is not observed with the corresponding sense probe (shown for the E12 forelimb in C). The arrows points to the apical
ectodermal ridge (AER). Bar for A±C, 10 mm.
chyme. Both HB-GAM transcript and protein were detected neuromuscular system. Starting from E16, HB-GAM was
found to accumulate as patches on the muscle cell surface.until birth, but only low or no expression was detected in
early (P0) postnatal tissue (not shown). Three examples are shown for stage E17 in Fig. 8.
The appearance of the patchy expression of HB-GAMSince proliferating cells apparently also exist in proximal
areas of the mesenchyme, the HB-GAM expression in the on the muscle cell surface at E16±E17 suggests its rela-
tionship to synapse formation, which occurs during thismesenchymal cells was compared to that of the PCNA
cyclin (Fig. 5). Cells that clearly express the PCNA cyclin time period (Hall and Sanes, 1993). Double immunostain-
ing using ¯uorescent a-bungarotoxin, which binds to nico-were found in the mesenchyme, close to the areas where
HB-GAM was also expressed. Interestingly, only low or no tinic acetylcholine receptors, showed that the HB-GAM
patches on the muscle cell surface actually correspond toexpression of HB-GAM was detected in PCNA-positive
cells (Fig. 5). Therefore, it seems that in the early (E12) developing neuromuscular synapses (Fig. 8). Antibodies to
the recombinant protein detected HB-GAM at most synap-mesenchyme the endogenous HB-GAM associates preferen-
tially with the surface of cells in which proliferation has tic sites on E16±E18, although lower amounts of HB-GAM
were also detected on the muscle cell surfaces outside thebeen arrested or is being arrested.
synapses (Fig. 8).
HB-GAM Expression in Differentiating (E15 to
Postnatal) Mesenchyme and Its Accumulation DISCUSSION
to Neuromuscular Synapses
HB-GAM and Cell ProliferationIn agreement with the expression of HB-GAM mRNA and
protein in the myogenic area of developing limb, double The role of the HB-GAM/MK-type proteins in develop-
ment is currently poorly understood. We have therefore at-immunostaining revealed that HB-GAM was associated
with cells expressing desmin (Fig. 6) and myosin heavy tempted to clarify this issue using developing limb, a model
widely used to de®ne signals required for proliferation, dif-chain (Fig. 7). In addition to the muscle cells, HB-GAM was
detected in neurite tracts (Fig. 6). Localization of HB-GAM ferentiation, and pattern formation (for reviews see Tabin,
1991; Tickle, 1995).to the neurite tracts was con®rmed by its colocalization
with the neuro®lament protein and with GAP 43/neuromo- Our results indicate that exogenous HB-GAM strongly
inhibits proliferation of mesenchymal cells in limb budsdulin (not shown). In order to ®nd further clues regarding
the putative role of HB-GAM in differentiation, we followed prepared from E12 embryos and kept in culture for 44 hr
in the presence of the recombinant protein. An inhibitoryfurther the expression of HB-GAM in the differentiating
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FIG. 5. Endogenous HB-GAM of the limb mesenchyme is mainly expressed in cells that do not express the PCNA cyclin. On E12 HB-
GAM-expressing cells (green color) are clearly observed in proximal areas of the mesenchyme (see also Fig. 4) but these are discerned from
the PCNA-expressing cells (red color) that express little or no HB-GAM. The sections were double-immunostained with af®nity-puri®ed
anti-recombinant HB-GAM antibodies (1 mg/ml) and with monoclonal anti-PCNA antibodies (10 mg/ml). The bound antibodies were
detected with af®nity-puri®ed FITC-conjugated goat anti-rabbit IgG and TRITC-conjugated goat anti-mouse IgG, respectively. The sections
were visualized with a laser confocal microscope. The micrographs represent two separate ®elds from the proximal part of the limb
mesenchyme. The arrow shows proximal-to-distal direction. The arrowheads point to HB-GAM-positive cells which are PCNA-negative.
Bars, 25 mm.
effect is also observed in epithelial cells, albeit to a lesser tin, 1992; deLapeyriere et al., 1993; Niswander et al., 1993;
Savage et al., 1993; Niswander et al., 1994; Fallon et al.,extent than that observed in the mesenchyme. HB-GAM
appears to suppress the proliferation-enhancing effect of 1994; Crossley and Martin, 1995; Mahmood et al., 1995).
Members of the FGF family depend on speci®c heparin-typebFGF. The concentration of HB-GAM (100 ng/ml) that
induces an almost complete proliferation arrest in the carbohydrate epitopes for proliferation-enhancing activity
(Yayon et al., 1991; Klagsbrun and Baird, 1991; Rapraegermesenchyme may not be very high when compared to HB-
GAM concentrations found in embryonic and perinatal et al., 1991; Ruoslahti and Yamaguchi, 1991; Turnbull et al.,
1992; Olwin and Rapraeger, 1992; Nurcombe et al., 1993;tissue (Rauvala, 1989). Estimates from quantitative West-
ern blotting (Rauvala, 1989) suggest that the concentra- Maccarana et al., 1993; Guimond et al., 1993; Walker et al.,
1994; Mason, 1994). The carbohydrate epitope that binds totions of HB-GAM in embryonic tissue might be at least
10- to 100-fold higher than bFGF concentrations. Further- HB-GAM has been recently characterized, and its character-
istics predict competition in the binding of HB-GAM andmore, immunostaining studies (Rauvala et al., 1994; Mit-
siadis et al., 1995) suggest rather high HB-GAM concentra- FGFs to naturally occuring carbohydrate ligands (Kinnunen
et al., 1996; Maccarana et al., 1993; Guimond et al., 1993;tions at the cell surface.
HB-GAM has been previously shown to be strongly ex- Walker et al., 1994). Competition between bFGF and HB-
GAM has also been directly demonstrated in the bindingpressed in developing limb (Vanderwinden et al., 1992;
Mitsiadis et al., 1995), but its mode of expression, espe- to the heparan sulfate chains of N-syndecan (Raulo et al.,
1994). From this point of view, it is possible that HB-GAMcially with reference to proliferating and/or differentiating
cell types, has not been characterized. The present ®nding exhibits its proliferation-inhibitory activity by depriving
some FGF form of its essential carbohydrate epitope re-that HB-GAM expression follows a proximal-to-distal pat-
tern and is associated with the surface of growth-arrested quired for mitogenic activity. However, further studies are
needed to test this hypothesis.cells suggests that the endogenous HB-GAM may indeed
have a role in cell proliferation arrest at the onset of cell Our current results are in agreement with previous
studies that have shown expression of HB-GAM in post-differentiation.
Several clues are currently available to explain the bio- mitotic neurons in vitro (Rauvala, 1989), in extracellular
tracts along growing axons in vivo (Rauvala et al., 1994;chemical mechanism of HB-GAM-induced proliferation ar-
rest. Fibroblast growth factors have essential roles in limb Matsumoto et al., 1994), and in growth-arrested 3T3 cells
(Merenmies, 1992). The neurite outgrowth-promoting ef-development (Vlodavsky et al., 1991; Niswander and Mar-
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FIG. 6. HB-GAM is expressed in the limb mesenchyme accompanying neuromuscular differentiation. Double immunostaining of sections
from E15 forelimb using af®nity-puri®ed anti-peptide antibodies to HB-GAM (2 mg/ml; A and C) and monoclonal anti-desmin antibodies
(2.5 mg/ml; B and D) detects HB-GAM in myogenic cells and in newly formed myotubes (arrowheads in A and B). In addition to the
differentiating muscle cells, HB-GAM is expressed in nerve tracts (arrowheads in C and D). Bar for A±D, 12 mm.
fect of HB-GAM (Rauvala, 1989; Li et al., 1990; Kuo et In light of the inhibitory effect of HB-GAM on cell
proliferation, it is somewhat unexpected that HB-al., 1990; Kretschmer et al., 1991; Hampton et al., 1992;
Muramatsu and Muramatsu, 1991; Nurcombe et al., GAM is reported to display cell-transforming activity
(Wellstein et al., 1992; Fang et al., 1992; Chauhan et al.,1992; Michikawa et al., 1993) is also compatible with a
role as a growth arrest gene. Further studies are, however, 1993; Czubayko et al., 1994). It is, however, known that
a protein that has cell-transforming activity can be awarranted to resolve the question whether HB-GAM
would have a role in cell-cycle exit in other cell types in growth inhibitor. For example, proteins of the trans-
forming growth factor-b superfamily are well-knownaddition to that found in early mesenchymal cells of the
limb bud. growth inhibitors and two members of this family (BMP-
2 and TGF-b1) also inhibit limb growth in vitro (Nis-Since HB-GAM appears to act on cells as an extracellu-
lar matrix-associated molecule, the contribution of phys- wander and Martin, 1993). It is also reasonable that
HB-GAM may function in a different manner in the celliologically occurring matrix structures to HB-GAM-in-
duced growth arrest requires further work. The ®ndings contacts of malignant cells compared to that in the mes-
enchymal cells in the present study. Alternatively, differ-that HB-GAM acts in cell contacts (Rauvala, 1989; Rau-
vala et al., 1994; Mitsiadis et al., 1995; Peng et al., 1995) ent forms of HB-GAM could be produced by different cell
types, as has been suggested (Laaroubi et al., 1994), andand that its expression is upregulated during cell contact-
dependent growth arrest (Merenmies, 1992) raise the in- these forms of HB-GAM might have different functional
properties compared to the major form of HB-GAM.triguing possibility that the growth-arresting role of HB-
GAM described in the present study might be one mecha- Whether an alternate form of HB-GAM exists in tissue is
an open question.nism in cell contact-dependent growth regulation.
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FIG. 7. HB-GAM is expressed in the differentiated muscle. Double immunostaining of sections from E15 forelimb using af®nity-puri®ed
polyclonal antibodies to HB-GAM (2 mg/ml; A) and monoclonal antibodies to myosin heavy chain protein (1:4; B). HB-GAM is localized
to the surface of the cells that express myosin heavy chain. Bar for A±B, 100 mm.
HB-GAM and Differentiation of the Neuromuscular lar synapse is a specialized domain of the muscle's base-
System ment membrane (Hall and Sanes, 1993). For example, he-
paran sulfate proteoglycans are known to be colocalized
Coexpression of HB-GAM with desmin and with the with acetylcholine receptor clusters at the developing
myosin heavy chain protein indicates that HB-GAM as- synapse (Anderson and Fambrough, 1983; Ferns et al.,
sociates with the surface of cells differentiating along the 1993). Extracellular matrix of the developing neuromus-
myogenic lineage. Accumulation of the HB-GAM mRNA cular junction is also known to contain essential infor-
to the proximal, differentiating mesenchyme supports mation for the development of the functional synapse
this inference. Since the expression of HB-GAM is not
(Hall and Sanes, 1993). Functional properties of HB-GAM
restricted to early myogenic differentiation in the limb
in inducing synapse formation (Peng et al., 1995) and its
mesenchyme, we followed the expression pattern at later
localization to the synaptic extracellular matrix both in
stages of development to ®nd further clues to the puta-
vitro and in vivo agree with the view that extracellulartive role of HB-GAM in limb development. On E16±E17,
matrix components are essential for synaptic differenti-just as the neuromuscular junctions start to form in the
ation.rat (Hall and Sanes, 1993), HB-GAM appears as patches
HB-GAM promotes neurite outgrowth in several typesat the neuromuscular junctions (Fig. 8), in manner simi-
of embryonic neurons, and we have recently shown thatlar to that recently demonstrated for the neuromuscular
substrates patterned with HB-GAM guide growing axonsjunctions of Xenopus (Peng et al., 1995). Interestingly,
of brain neurons (Rauvala et al., 1994). This suggests thatagrin, which is thought to play a major role in synapse
growth cones of developing axons grow into HB-GAM-formation (McMahan, 1990), also appears at the nerve ±
rich areas in vitro. The present ®nding that HB-GAM ismuscle synapses of the rat at E16 (Hoch et al., 1993). The
already present on the muscle cell surface before the ar-functional roles of agrin (McMahan, 1990) and HB-GAM
rival of axons suggests, together with previously studied(Peng et al., 1995) are also similar in that both have been
in vitro properties of the protein, that HB-GAM at theimplicated in the differentiation of the endplates in mus-
muscle cell surface could help the growth cones to growcle cells. However, the role of HB-GAM in neuromuscu-
toward their targets and to initiate synapse formation.lar synapses may be restricted to an earlier develop-
Our immunostaining results suggest that synapse forma-mental stage compared to that of agrin since the
tion occurs on areas where the HB-GAM concentrationHB-GAM expression in the synapses becomes clearly
is higher than on nonjunctional areas. In addition to thedecreased shortly after birth when agrin expression in
muscle cell surface, HB-GAM was also detected in thethe synapses is still high (Hoch et al., 1993). The HB-
present study in neurite pathways that grow into the limbGAM transcript was not detected in limb muscles of the
mesenchyme, in agreement with the neurite-promotingnewborn rats either.
property and with the previously demonstrated synthesisThe expression of HB-GAM in developing synaptic
of HB-GAM in Schwann cells and in early neurons (Van-structures is compatible with the ®nding that HB-GAM
derwinden et al., 1992).associates in cells and tissues with heparan sulfate (Raulo
The active promoter sequence of the HB-GAM geneet al., 1994) and is deposited to the extracellular matrix.
The extracellular matrix at the developing neuromuscu- contains several consensus (CANNTG) sequences for
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FIG. 8. HB-GAM accumulates to developing neuromuscular synapses. Sections of E17 forelimb were stained by anti-recombinant HB-
GAM antibodies (1 mg/ml) followed by FITC-conjugated anti-rabbit IgG (A, C, and E). Acetylcholine receptors at the muscle membrane
were detected with a-bungarotoxin (0.5 mg/ml; B, D, and F). HB-GAM is expressed along the muscle cell surface and accumulates to newly
formed neuromuscular junctions (arrowheads). Bar for A±F, 6 mm.
MyoD binding (Li et al., 1992; Milner et al., 1992), which subunits is controlled by transcription factors of the
MyoD family (Salpeter et al., 1992). Further work is, how-offers a putative explanation to our ®nding that the HB-
GAM expression in developing limb is linked to prolifera- ever, required to unravel the biochemical mechanisms
linking HB-GAM to the differentiation of the neuromus-tion arrest/myogenic differentiation. For example, the
expression of the muscle-speci®c acetylcholine receptor cular system.
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